Reconstitution of a human immune system in immunodeficient mice: Models of human alloreaction in vivo

Tissue Antigens

Volumn 66, Issue 2, 2005, Pages 73-82

  Thomsen, Mogens ^a   Yacoub Youssef, H ^a   Marcheix, B ^a  

^a CHU RANGUEIL   (France)

Author keywords

Alloreaction; Graft vs host disease; Humanized mice; Lymphoid cells; MHC; Stem cells; Transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIBODY RESPONSE; B LYMPHOCYTE; CELL INFILTRATION; CLINICAL PRACTICE; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; RODENT; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; MESENTERIC ARTERIES; MICE; MICE, INBRED NOD; MICE, MUTANT STRAINS; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

RODENTIA;

EID: 22644441115     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00409.x     Document Type: Review

References (62)

1. Gregersen JW, Holmes S, Fugger L. Humanized animal models for autoimmune diseases. Tissue Antigens 2004: 63: 383-94.
2. Chang CH, Fodor WL, Flavell RA. Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J Exp Med 1992: 176: 1465-9.
3. + regulatory T cells. Semin Immunol 2004: 16: 89-98.
4. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988: 335: 256-9.
5. Berney T, Molano RD, Pileggi A et al. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 2001: 72: 133-40.
6. Flanagan SP. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 1966: 8: 295-309.
7. Rygaard J, Povlsen CO. Heterotransplantation of a human malignant tumour to 'Nude' mice. Acta Pathol Microbiol Scand 1969: 77: 758-60.
8. Scher I, Ahmed A, Strong DM, Steinberg AD, Paul WE. X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med 1975: 141: 788-803.
9. Wortis HH, Burkly L, Hughes D, Roschelle S, Waneck G. Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med 1982: 155: 903-13.
10. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983: 301: 527-30.
11. Fulop GM, Phillips RA. The scid mutation in mice causes a general defect in DNA repair. Nature 1990: 347: 479-82.
12. Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature 1979: 278: 451-3.
13. Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL. Homozygous scid/scid; beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med 1993: 177: 191-4.
14. Makino S, Kunimoto K, Muraoka Y et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980: 29: 1-13.
15. Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992: 89: 3290-4.
16. + T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997: 158: 3578-86.
17. Rothenberg BE, Voland JR. beta2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996: 93: 1529-34.
18. Ito M, Hiramatsu H, Kobayashi K et al. NOD/SCID/gamma (c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002: 100: 3175-82.
19. Shultz LD, Lang PA, Christianson SW et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000: 164: 2496-507.
20. Shultz LD, Banuelos S, Lyons B et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 2003: 76: 1036-42.
21. Westphal CH, Leder P. Transposon-generated 'knock-out' and 'knock-in' gene-targeting constructs for use in mice. Curr Biol 1997: 7: 530-3.
22. Martino G, Anastasi J, Feng J et al. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol 1993: 23: 1023-8.
23. Hoffmann-Fezer G, Gall C, Zengerle U, Kranz B, Thierfelder S. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993: 81: 3440-8.
24. Huppes W, De Geus B, Zurcher C, Van Bekkum DW. Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice. Eur J Immunol 1992: 22: 197-206.
25. Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 1992: 22: 1421-7.
26. + T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 1994: 180: 1817-27.
27. Shibata S, Asano T, Noguchi A et al. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes. Immunology 1998: 93: 524-32.
28. Santini SM, Spada M, Parlato S et al. Treatment of severe combined immunodeficiency mice with anti-murine granulocyte monoclonal antibody improves human leukocyte xenotransplantation. Transplantation 1998: 65: 416-20.
29. Tournoy KG, Depraetere S, Pauwels RA, Leroux-Roels GG. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice. Clin Exp Immunol 2000: 119: 231-9.
30. Christianson SW, Greiner DL, Schweitzer IB et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol 1996: 171: 186-99.
31. Alegre ML, Peterson LJ, Jeyarajah DR et al. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol 1994: 153: 2738-49.
32. Sandhu J, Shpitz B, Gallinger S, Hozumi N. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol 1994: 152: 3806-13.
33. Wagar EJ, Cromwell MA, Shultz LD et al. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol 2000: 165: 518-27.
34. Yacoub-Youssef H, Marcheix B, Calise D et al. Use of human mesenteric arteries to study chronic vascular rejection in SCID/Beige mice reconstituted with human spleen cells. Transpl Proc 2005: 37: 75-6.
35. McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988: 241: 1632-9.
36. + cells using the NOD/SCID/gammacnull mice model. Blood 2003: 102: 873-80.
37. Murray AG, Petzelbauer P, Hughes CC et al. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sa USA 1994: 91: 9146-50.
38. Takakura I, Yabe M, Kato Y et al. An in vivo model of human skin acute graft-versus-host disease: transplantation of cultured human epidermal cells and dermal fibroblasts with human lymphocytes into SCID mice. Exp Hematol 1999: 27: 1815-21.
39. Reinders ME, Sho M, Izawa A et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003: 112: 1655-65.
40. Rayner D, Nelson R, Murray AG. Noncytolytic human lymphocytes injure dermal microvessels in the huPBL-SCID skin graft model. Hum Immunol 2001: 62: 598-606.
41. Snanoudj R, Rouleau M, Bidere N et al. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells. Transplantation 2004: 78: 50-8.
42. Kirkiles-Smith NC, Mahboubi K, Plescia J et al. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J Immunol 2004: 172: 1391-6.
43. Libby P, Pober JS. Chronic rejection. Immunity 2001: 14: 387-97.
44. Lorber MI, Wilson JH, Robert ME et al. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation 1999: 67: 897-903.
45. Dambrin C, Calise D, Pieraggi MT, Thiers JC, Thomsen M. Orthotopic aortic transplantation in mice: a new model of allograft arteriosclerosis. J Heart Lung Transplant 1999: 18: 946-51.
46. Tereb DA, Kirkiles-Smith NC, Kim RW et al. Human T cells infiltrate and injure pig coronary artery grafts with activated but not quiescent endothelium in immunodeficient mouse hosts. Transplantation 2001: 71: 1622-30.
47. Koh KP, Wang Y, Yi T et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest 2004: 114: 846-56.
48. Shiroki R, Poindexter NJ, Woodle ES et al. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Transplantation 1994: 57: 1555-62.
49. Banuelos SJ, Shultz LD, Greiner DL et al. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1 (null) Prf1 (null) mice. Clin Immunol 2004: 112: 273-83.
50. Lazarus AH, Crow AR, Semple JW et al. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes. Transfusion 1997: 37: 1192-9.
51. Shoker AS, Lun ZR, Choudry R. Cytokine gene expression by alloactivated cells in SCID mice. Transpl Immunol 2002: 10: 311-20.
52. Zhou W, Ohdan H, Tanaka Y et al. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Transpl Immunol 2003: 12: 9-18.
53. + regulatory T cells. I. Phenotype and physiology. Apmis 2004: 112: 629-41.
54. Shimizu K, Mitchell RN. Stem cell origins of intimal cells in graft arterial disease. Curr Atheroscler Rep 2003: 5: 230-7.
55. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003: 108: 2070-3.
56. + cells regenerate gastrointestinal epithelial cells. Faseb J 2004: 18: 1958-60.
57. Yang YG, Wood JC, Lan P et al. Mouse retrovirus mediates porcine endogenous retrovirus transmission into human cells in long-term human-porcine chimeric mice. J Clin Invest 2004: 114: 695-700.
58. Jicha DL, Yannelli JR, Custer M et al. The persistence of human peripheral lymphocytes, tumor infiltrating lymphocytes, and colon adenocarcinomas in immunodeficient mice. J Immunother 1992: 11: 19-29.
59. + T cells. Science 1990: 248: 1227-30.
60. Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perform gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994: 91: 11571-5.
61. Ohbo K, Suda T, Hashiyama M et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 1996: 87: 956-67.
62. Mombaerts P, Iacomini J, Johnson RS et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992: 68: 869-77.